Literature DB >> 24433638

Oral antimicrobials increase antimicrobial resistance in porcine E. coli--a systematic review.

E Burow1, C Simoneit2, B-A Tenhagen2, A Käsbohrer2.   

Abstract

Administration of antimicrobials to livestock increases the risk of antimicrobial resistance (AMR) in commensal bacteria. Antimicrobials in pig production are usually administered per pen via feed which implies treatment of sick alongside with healthy animals. The objective of this systematic literature review was to investigate the effect of orally administered antimicrobials on AMR in Escherichia coli of swine. Studies published in peer reviewed journals were retrieved from the international online databases ISI Web of Knowledge, PubMed, Scopus and the national electronic literature data base of Deutsches Institut für Medizinische Dokumentation und Information. The studies were assessed using the eligibility criteria English or German language, access to full paper version, defined treatment and control group (initial value or non-treatment) as well as administration and resistance testing of the same antimicrobial class. In the qualitative synthesis, only studies were included presenting the summary measures odds ratio or prevalence of resistance, the category of the applied antimicrobial and the dosage. An effect of the antimicrobial on AMR in E. coli was evaluated as an "increase", "no effect" or "decrease" if the odds or alternatively the prevalence ratio were >1.0, 1.0 or <1.0, respectively. Eleven studies, describing 36 different trials, fulfilled the eligibility criteria and were finally assessed. An increase of AMR in E. coli was found in 10 out of 11 trials comparing AMR after with AMR prior to oral treatment and in 22 of the 25 trials comparing orally treated with untreated groups. Effects expressed as odds or prevalence ratios were highest for the use of aminoglycosides, quinolones and tetracycline. There was no clear association between the reported dosage and AMR towards tetracycline. Information on antimicrobial substance and dosage was missing in 4 and 5 of the 11 finally selected studies. The 36 identified trials were inhomogenous in usage and provision of information on sample size. Oral administration of antimicrobials increases the risk of AMR in E. coli from swine. There is however a lack of studies on the impact of dosage and longitudinal effects of treatment. The published studies have a number of issues concerning their scientific quality. More high quality research is needed to better address and quantifiy the effect of orally administered antimicrobials on AMR in swine.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobials; E. coli; Oral; Porcine; Resistance; Swine

Mesh:

Substances:

Year:  2013        PMID: 24433638     DOI: 10.1016/j.prevetmed.2013.12.007

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  34 in total

1.  Resistance and Virulence Mechanisms of Escherichia coli Selected by Enrofloxacin in Chicken.

Authors:  Jun Li; Haihong Hao; Menghong Dai; Heying Zhang; Jianan Ning; Guyue Cheng; Muhammad Abu Bakr Shabbir; Abdul Sajid; Zonghui Yuan
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Effect of Tetracycline Dose and Treatment Mode on Selection of Resistant Coliform Bacteria in Nursery Pigs.

Authors:  Kaare Græsbøll; Peter Damborg; Anders Mellerup; Ana Herrero-Fresno; Inge Larsen; Anders Holm; Jens Peter Nielsen; Lasse Engbo Christiansen; Øystein Angen; Shahana Ahmed; Anders Folkesson; John Elmerdahl Olsen
Journal:  Appl Environ Microbiol       Date:  2017-05-31       Impact factor: 4.792

3.  Antimicrobial Resistance in Commensal Escherichia coli Isolated from Pigs and Pork Derived from Farms Either Routinely Using or Not Using In-Feed Antimicrobials.

Authors:  Kittitat Lugsomya; Jitrapa Yindee; Waree Niyomtham; Chanwit Tribuddharat; Padet Tummaruk; David J Hampson; Nuvee Prapasarakul
Journal:  Microb Drug Resist       Date:  2018-09       Impact factor: 3.431

Review 4.  Swine enteric colibacillosis: diagnosis, therapy and antimicrobial resistance.

Authors:  Andrea Luppi
Journal:  Porcine Health Manag       Date:  2017-08-08

Review 5.  The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin.

Authors:  Manjusha Lekshmi; Parvathi Ammini; Sanath Kumar; Manuel F Varela
Journal:  Microorganisms       Date:  2017-03-14

6.  Use of Colistin and Other Critical Antimicrobials on Pig and Chicken Farms in Southern Vietnam and Its Association with Resistance in Commensal Escherichia coli Bacteria.

Authors:  Nhung T Nguyen; Hoa M Nguyen; Cuong V Nguyen; Trung V Nguyen; Men T Nguyen; Hieu Q Thai; Mai H Ho; Guy Thwaites; Hoa T Ngo; Stephen Baker; Juan Carrique-Mas
Journal:  Appl Environ Microbiol       Date:  2016-06-13       Impact factor: 5.005

7.  Understanding the culture of antimicrobial prescribing in agriculture: a qualitative study of UK pig veterinary surgeons.

Authors:  L A Coyne; S M Latham; N J Williams; S Dawson; I J Donald; R B Pearson; R F Smith; G L Pinchbeck
Journal:  J Antimicrob Chemother       Date:  2016-08-11       Impact factor: 5.790

8.  Association between selected antimicrobial resistance genes and antimicrobial exposure in Danish pig farms.

Authors:  Anna Camilla Birkegård; Tariq Halasa; Kaare Græsbøll; Julie Clasen; Anders Folkesson; Nils Toft
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

9.  Antimicrobial use and antimicrobial susceptibility in Escherichia coli on small- and medium-scale pig farms in north-eastern Thailand.

Authors:  G Ström; M Halje; D Karlsson; J Jiwakanon; M Pringle; L-L Fernström; U Magnusson
Journal:  Antimicrob Resist Infect Control       Date:  2017-07-17       Impact factor: 4.887

10.  Antimicrobials in small-scale urban pig farming in a lower middle-income country - arbitrary use and high resistance levels.

Authors:  G Ström; S Boqvist; A Albihn; L-L Fernström; A Andersson Djurfeldt; S Sokerya; T Sothyra; U Magnusson
Journal:  Antimicrob Resist Infect Control       Date:  2018-03-07       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.